
Sign up to save your podcasts
Or


Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
By John Simboli5
77 ratings
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

535 Listeners

3,079 Listeners

1,094 Listeners

938 Listeners

796 Listeners

124 Listeners

324 Listeners

92 Listeners

9,953 Listeners

33 Listeners

498 Listeners

147 Listeners

353 Listeners

171 Listeners

512 Listeners